These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15570543)

  • 1. [Psychopharmacotherapy in psychiatric nursing homes: myth and reality].
    Krüninger U; Herpich S; Schreiber W
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S170-2. PubMed ID: 15570543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic treatment by the established psychiatrist. A report of experiences].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 1998 Nov; 25(6):284-5. PubMed ID: 9885840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
    Snowdon J; Day S; Baker W
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
    Alam DA; Janicak PG
    Essent Psychopharmacol; 2005; 6(3):127-40. PubMed ID: 15869020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of antipsychotics to medication regimens during schizophrenic inpatient care.
    Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication and length of stay at a psychiatric maximum-security unit in Norway (1987-2000).
    Renkel S; Rasmussen K
    Nord J Psychiatry; 2006; 60(2):132-6. PubMed ID: 16635932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
    Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
    Am J Geriatr Psychiatry; 2007 May; 15(5):416-24. PubMed ID: 17463191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
    Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany].
    Vogel M; Köhnlein O; Schmauss M; Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S173-4. PubMed ID: 15570544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M; Scheel T; Eich FX
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Withdrawal of neuroleptics--a successful project at a nursing home for the mentally retarded].
    Näslund I
    Lakartidningen; 1992 Jun; 89(23):2084. PubMed ID: 1352838
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
    Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
    Schneider AL; Mosier KE; Tempier RP
    J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.